Buradasınız

A study of clinical manifestations of PCOS among obese and non- obese rural women

Journal Name:

Publication Year:

Abstract (2. Language): 
Introduction: The present study was planned to determine the prevalence of various clinical manifestations in obese and nonobese PCOS women in rural population. Materials and methods : 100 consecutive PCOS women were divided in non- obese(BMI<23) and obese (BMI>23) groups .The prevalence of various clinical parameters like menstrual irregularities, clinical hyperandrogenism, android obesity, hypertension and other cutaneous manifestations like acanthosis nigricans, achrochordons were compared between the two groups. Results: There were 25% of PCOS women with normal BMI. The prevalence of android obesity was significantly high in obese group. The prevalence of menstrual irregularities, hirsutism, acne, androgenic alopecia, hypertension and pre hypertension were similar in both groups. Acanthosis nigricans, achrochordons and striae distensae were more prevalent in obese group. Conclusion: There were no major differences in clinical manifestations in obese and non- obese PCOS women probably indicating inherent insulin resistance in PCOS irrespective of BMI .The prevalence of obesity (30%) and over weight ( 45%) in rural women is of concern.
FULL TEXT (PDF): 
946-951

REFERENCES

References: 

1.Frank S, Gharani N and McCathy M. Candidates genes in Polycystic Ovary Syndrome. Hum Reprod 2001; update
405-410.
2.Elsenbruch s, Hahn s, Kowalsky D, et al Quality of life ,Psychosocial well being and sexual satisfaction in
women with polysystic ovarian syndrome. J clin endocrinol metab 2003; 88:5801-7.
Indian Journal of Basic & Applied Medical Research; September 2013: Issue-8, Vol.-2, P. 946-951
951
www.ijbamr.com
3. Bonnar J, Dunlop W, editors.Recent advances in obstetrics and gynaecology vol 23.London: Royal society of
medicine press limited; 2005
4. Choo v.WHO reassesses appropriate BMI for Asian population. The Lancet 2002; 360:235.
5. Falsetti L, Gambera A, Andrico S, Sartori E.Acne and Hirsuitism in PCOS. Clinical, endocrine- metabolic and
ultrasonographic differences. Gynecol endocrinol 2002; 16:275-84.
6.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The seventh report of the Joint
national committee on prevention,detection, evaluation and treatment of high blood pressure: JNC 7 report. JAMA
2003 May 21 ;289:2560-72.
7.Majumdar A, Singh TA. Comparison of clinical features and health manifestations in lean vs obese Indian women
with polycystic ovarian syndrome. J Hum Reprod Sci 2009;2:12-17.
8.Snehalatha C, Ramachandran A, Kapur A, Vijay V. Age specific prevalence and risk associations for impaired
glucose tolerance in urban southern Indian population. J Assoc Physicians India 2003;51:766-9.
9.Saxena P, Prakash A, Nigam A, Mishra A. Polycystic ovarian syndrome: Is obesity a sine qua non ?A clinical,
hormonal and metabolic assesment in relation to body mass index. Indian J Endocr Metb 2012;16:996-9.
10.S.S. Lim, M.J Davis, R.J Norman and L.J.Moran. Overweight, obesity and central obesity in women with
polycystic ovarian syndrome: A systemic review and meta-analysis. Hum Reprod update 2012;18(6):618-637.
11.Balen AH, Conway GS, Kaltas G, Techatraisak K, Manning PJ, West C et al .Polycystic ovarian syndrome: The
spectrum of disorder in 1741 patients. Hum Reprod 1995;10:2107-11.
12. Demir B, Pasa S, Demir S, Tumer C, Atay AE, Gul T and Atamer Y. Hirsutism score and the severity of
hyperandrogenism associated with polycystic ovarian syndrome in south-eastern region of Turkey. The Journal of
International Medical Research 2011;39:1529-1535.
13.Hud Jr JA, Cohen J B, Wagner JM. Prevalance and significance of acanthosis nigricancs in an adult obese
population. Arch Dermatol 1992;128:941-4.

Thank you for copying data from http://www.arastirmax.com